Abstract

BackgroundAdalimumab and etanercept are both anti-TNF drugs used to treat various autoimmune pathologies.PurposeThe purpose of this study was to evaluate the use of adalimumab and etanercept in authorised and unauthorised...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call